Cancer

June is National Cancer Survivors Month! To honor survivors, we will be sharing stories from folks with cancer and their caregivers. Today we hear from Marlys. It was the sunny month of July. We were sharing a vacation rental with our daughter, son-in-law, and the grandkids in a nearby mountain village. My husband’s cancer was

JoAnn Carroll lives in South Carolina, but she’s been self-evacuated to her condo in Florida for the last few months as she waits for the air in and around her home to become cleaner and more breathable. When JoAnn and her husband first left for the condo in January, she says there was no issue.

Screening tests mark a turning point in early detection of cancers. The first screening test widely used to detect cancer, developed by George Papanicolaou, was the Pap test. Although Papanicolaou presented his findings in 1923, it wasn’t until the early 1960s, when the Pap test was backed by the American Cancer Society (ACS), that doctors

Lung adenocarcinoma cells, a type of non small cell lung cancer (NSCLC) One of the biggest meetings of the world’s cancer specialists took place this weekend. Usually located in Chicago, researchers and clinicians around the world met virtually this year to present the latest in cancer research at the American Society of Clinical Oncology (ASCO)

Breast cancer is essentially incapable of taking a life as long as it stays in a person’s breasts and doesn’t spread to other areas of the body. When it metastasizes to important organs like the liver, lungs, bones, or brain, however, it can have disastrous consequences. Therefore, it’s important that breast cancer research emphasizes understanding

Prostate cancer cells. Prostate cancer cells viewed under a microscope. Men with advanced, hormone-sensitive prostate cancer will now have another treatment option in England, following the approval of the hormone therapy enzalutamide (Xtandi). The National Institute of Health and Care Excellence (NICE) has approved the combination of enzalutamide and androgen deprivation therapy (ADT) for adults

Triple negative breast cancer (TNBC) lacks all three of the common receptors found in breast cancer, which makes it harder to treat. The disease also spreads faster and has a worse prognosis. A new study out of Canada may have found a better treatment option for it, though. In a preclinical study, a team from

Breast cancer recurrence is a strong concern of patients after their initial treatment ends. There may be some good news on this front for those with mutations that make them higher-risk. British drug manufacturer AstraZeneca shared promising results of the OlympiA Phase III trial on its cancer drug Lynparza in The New England Journal of

June is National Cancer Survivors Month! To honor survivors, we will be sharing stories from folks with cancer and their caregivers. Today we hear from Erin. 37-Year-Old Cancer Survivor and Mom of Four Shares Her Survival Story to Help Others An advanced Stage III colon cancer diagnosis was the last thing I expected to receive

A husband grieving the loss of his wife to breast cancer was left with an unused package of her medication. Not wanting to see that reminder and hoping to help other breast cancer patients, he asked if he could donate the prescription to someone in need. Unfortunately, no one would allow it. Ed Casaccia lost

A patient website that supports cancer patients and their family caregivers Confronting a cancer diagnosis is one of the most demanding, isolating things you can do. Family and friends are an amazing source of support, but constantly sharing updates with each and every one of them is impractical. So what resources are available to families

For the next stop on our virtual tour around the UK meeting the directors of our research centres and institutes, we speak with Professor Ian Tomlinson, who heads up the Cancer Research UK Edinburgh Centre. When geneticist and clinician researcher Professor Ian Tomlinson took over as director of our Cancer Research UK Edinburgh Centre in

Our partnership with ScottishPower began in 2012, since then it’s raised over £30m. We’re thrilled to announce that we’re extending this extraordinary partnership for another three years. This means that the incredible employees, suppliers and customers of ScottishPower will continue to help us fund our life-saving research until 31 March 2024. Alongside their creative fundraising

A young woman who is fighting for her own life after a terminal cancer diagnosis is using what’s left of her time on this planet to help other people who also have cancer. Jill Bertolini, from Salem, Connecticut, has a unique story to tell. She was first diagnosed with breast cancer in August of 2019,

Variations in the human gut microbiome have been linked to cancer – an exciting prospect for cancer prevention, but teasing apart causation from correlation is no easy task says Dr Kaitlin Wade… Cancer remains one of the leading causes of death worldwide as well as one of the greatest economical burdens on health care systems.

Mothers keep their babies safe from danger every day, but it’s rare that we hear about a baby keeping a mother safe or even saving her life. In the case of 30-year-old Claire Hilton-Ellison and her unborn son, however, that’s exactly what appears to have happened. At first, Claire’s pregnancy seemed like any other. But

The COVID-19 pandemic has been mentally taxing for many people. The isolation, the fear of contracting the virus, and employment stress are just some of the issues we have faced. A new study finds that cancer patients have dealt with serious impacts to their mental health, as well. Researchers from University of California San Francisco

May is Mental Health Awareness Month. Over the next few weeks, OncoLink will feature blogs about common mental health challenges faced by cancer patients, caregivers, and healthcare professionals. Please remember, if you are in crisis, help is available. National Suicide Prevention Lifeline 800-273-8255 National Alliance on Mental Health (NAMI) Helpline 800-950-6264 A caregiver is someone

When Deb Shaffer was diagnosed with an aggressive form of breast cancer, her doctor told her that she might make it two more years. But for Deb, that wasn’t nearly enough. “At the time, my oncologist gave me two years, and I found that completely unacceptable,” she recalls. “Especially on the day of my first

Cancer treatments carry with them plenty of side effects, including gastrointestinal issues. Diarrhea and constipation are especially common. These can make treatment all the more unpleasant and even cause lingering issues. However, a new study may have found a way to protect gut health from chemotherapy. Researchers at Northwestern University tested how certain types of

Achilles Therapeutics has been listed and is open to public investment on the world’s second largest stock exchange Cancer Research UK’s spinout, Achilles Therapeutics plc (‘Achilles’), has raised $175.5 million to invest in the development of new cancer immunotherapies through the closing of its initial public offering (IPO). This milestone marks the ‘birth’ of a

The BBC’s Jane Hill (top left) was joined by our expert panel of cancer researchers. Behind the Science is an annual panel discussion providing supporters with an exclusive opportunity to hear directly from experts working in a specific area of our cutting-edge research portfolio. This year’s event took place virtually on Wednesday 12 May and